This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Aug;19(8):e366.

doi: 10.1016/S1470-2045(18)30439-X.

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation

Tim J Kruser¹, Vinai Gondi², Paul W Sperduto³, Paul D Brown⁴, Minesh P Mehta⁵

Affiliations

Affiliations

¹ Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: tkruser@nm.org.
² Northwestern Medicine Chicago Proton Center, Warrenville, IL, USA.
³ Gamma Knife Center, University of Minnesota, Waconia, MN, USA.
⁴ Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
⁵ Miami Cancer Institute, Miami, FL, USA.

PMID: 30102216
DOI: 10.1016/S1470-2045(18)30439-X

Comment

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation

Tim J Kruser et al. Lancet Oncol. 2018 Aug.

. 2018 Aug;19(8):e366.

doi: 10.1016/S1470-2045(18)30439-X.

Authors

Tim J Kruser¹, Vinai Gondi², Paul W Sperduto³, Paul D Brown⁴, Minesh P Mehta⁵

Affiliations

¹ Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: tkruser@nm.org.
² Northwestern Medicine Chicago Proton Center, Warrenville, IL, USA.
³ Gamma Knife Center, University of Minnesota, Waconia, MN, USA.
⁴ Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
⁵ Miami Cancer Institute, Miami, FL, USA.

PMID: 30102216
DOI: 10.1016/S1470-2045(18)30439-X

No abstract available

PubMed Disclaimer

Comment in

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation - Authors' reply.
Long GV, Atkinson V, Hong A, McArthur GA, Menzies AM. Long GV, et al. Lancet Oncol. 2018 Aug;19(8):e367. doi: 10.1016/S1470-2045(18)30508-4. Lancet Oncol. 2018. PMID: 30102217 No abstract available.

Comment on

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, Wilmott JS, Edwards J, Gonzalez M, Scolyer RA, Menzies AM, McArthur GA. Long GV, et al. Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27. Lancet Oncol. 2018. PMID: 29602646 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information